ahlam1399
03-15-2016, 04:22 PM
UPDATE 1-Valeant cuts 2016 revenue forecast
March 15 (Reuters) – Valeant Pharmaceuticals International Inc cut its revenue forecast for the year by about 12 percent, or $1.5 billion, citing slower growth in its U.S. dermatology,…http://feeds.feedburner.com/~ff/reuters/hotStocksNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=25HpO7pBa44:vfycxUrqzbI:yIl2AUoC8z A) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=25HpO7pBa44:vfycxUrqzbI:F7zBnMyn0L o (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=25HpO7pBa44:vfycxUrqzbI:F7zBnMyn0L o) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=25HpO7pBa44:vfycxUrqzbI:V_sGLiPBpW U (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=25HpO7pBa44:vfycxUrqzbI:V_sGLiPBpW U)
http://feeds.feedburner.com/~r/reuters/hotStocksNews/~4/25HpO7pBa44
March 15 (Reuters) – Valeant Pharmaceuticals International Inc cut its revenue forecast for the year by about 12 percent, or $1.5 billion, citing slower growth in its U.S. dermatology,…http://feeds.feedburner.com/~ff/reuters/hotStocksNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=25HpO7pBa44:vfycxUrqzbI:yIl2AUoC8z A) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=25HpO7pBa44:vfycxUrqzbI:F7zBnMyn0L o (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=25HpO7pBa44:vfycxUrqzbI:F7zBnMyn0L o) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=25HpO7pBa44:vfycxUrqzbI:V_sGLiPBpW U (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=25HpO7pBa44:vfycxUrqzbI:V_sGLiPBpW U)
http://feeds.feedburner.com/~r/reuters/hotStocksNews/~4/25HpO7pBa44